BioCentury | Sep 12, 2020
Management Tracks

New CEO Hirsch to guide C4 onto NASDAQ; plus Biller adds CFO title at Agios and updates from Sherlock, Lumen and more

...Spigarelli as CMO. Spigarelli was VP, medical affairs for Immucor Inc. (see “Lumen $16M Series B”). Sensyne Health plc...
BioCentury | Aug 2, 2019
Company News

Bayer, Sensyne to use AI platform to accelerate CV development

...the company plans to build the database out to 5 million patients. Under the deal, Sensyne Health plc...
...out AI and digital health-focused companies from the University of Oxford. Elizabeth S. Eaton, Staff Writer Bayer AG Sensyne Health plc...
BioCentury | Jun 24, 2019
Company News

June 24 Company Quick Takes: Terns gains Chinese rights to elafibranor; plus venetoclax, Zejula and more

...Gains Zejula" ). Sensyne, Evotec partner to spin out AI research at Oxford AI company Sensyne Health plc...
...Other) Zejula (Brand), ZL-2306 (Compound #), MK-4827 (Compound #), niraparib (Generic), Zejula (Informal) AbbVie Inc. Evotec AG Genfit S.A. GlaxoSmithKline plc Sensyne Health plc Terns...
BioCentury | May 1, 2019
Company News

April 30 Company Quick Takes: Merck, G1, Pfizer, Amgen and more

...patients. Bayer, Sensyne Health partner to analyze patient data Bayer AG (Xetra:BAYN) will collaborate with Sensyne Health plc...
...AG EirGenix Inc. G1 Therapeutics Inc. Johnson & Johnson Luye Pharma Group Ltd. Merck & Co. Inc. Novan Inc. Novartis AG Pfizer Inc. PharmaMar S.A. Sandoz Sensyne Health plc Vertex...
BioCentury | Feb 1, 2019
Company News

Sensyne, University of Oxford to use AI and data science to evaluate NHS patient data

...Jan. 27, the day before the deal was announced. Wye is eligible for shared royalties. Sensyne Health plc...
...Oxford, U.K. University of Oxford, Oxford, U.K. Wye Valley NHS Trust, Hereford, U.K. Business: Renal/Cardiovascular Shannon Lehnbeuter Sensyne Health plc University...
BioCentury | Jan 12, 2019
Finance

Warning: cash needed

...A) 8/21/18 $23.7 NA $52.6 NA Biosolution Co. Ltd. (KOSDAQ:086820) 8/20/18 $38.8 $198.0 $222.1 12% Sensyne Health plc...
BioCentury | Aug 10, 2018
Financial News

Sensyne proposes London IPO

...Data analysis company Sensyne Health plc (Oxford, U.K.) proposed to raise £60 million ($78 million) in an IPO...
...the University of Oxford. In 1993, Bell founded the Wellcome Trust Centre for Human Genetics. Sensyne Health plc...
BioCentury | Aug 7, 2018
Financial News

Sensyne proposes London IPO

...Data analysis company Sensyne Health plc (Oxford, U.K.) proposed to raise £60 million ($78 million) in an IPO...
Items per page:
1 - 8 of 8
BioCentury | Sep 12, 2020
Management Tracks

New CEO Hirsch to guide C4 onto NASDAQ; plus Biller adds CFO title at Agios and updates from Sherlock, Lumen and more

...Spigarelli as CMO. Spigarelli was VP, medical affairs for Immucor Inc. (see “Lumen $16M Series B”). Sensyne Health plc...
BioCentury | Aug 2, 2019
Company News

Bayer, Sensyne to use AI platform to accelerate CV development

...the company plans to build the database out to 5 million patients. Under the deal, Sensyne Health plc...
...out AI and digital health-focused companies from the University of Oxford. Elizabeth S. Eaton, Staff Writer Bayer AG Sensyne Health plc...
BioCentury | Jun 24, 2019
Company News

June 24 Company Quick Takes: Terns gains Chinese rights to elafibranor; plus venetoclax, Zejula and more

...Gains Zejula" ). Sensyne, Evotec partner to spin out AI research at Oxford AI company Sensyne Health plc...
...Other) Zejula (Brand), ZL-2306 (Compound #), MK-4827 (Compound #), niraparib (Generic), Zejula (Informal) AbbVie Inc. Evotec AG Genfit S.A. GlaxoSmithKline plc Sensyne Health plc Terns...
BioCentury | May 1, 2019
Company News

April 30 Company Quick Takes: Merck, G1, Pfizer, Amgen and more

...patients. Bayer, Sensyne Health partner to analyze patient data Bayer AG (Xetra:BAYN) will collaborate with Sensyne Health plc...
...AG EirGenix Inc. G1 Therapeutics Inc. Johnson & Johnson Luye Pharma Group Ltd. Merck & Co. Inc. Novan Inc. Novartis AG Pfizer Inc. PharmaMar S.A. Sandoz Sensyne Health plc Vertex...
BioCentury | Feb 1, 2019
Company News

Sensyne, University of Oxford to use AI and data science to evaluate NHS patient data

...Jan. 27, the day before the deal was announced. Wye is eligible for shared royalties. Sensyne Health plc...
...Oxford, U.K. University of Oxford, Oxford, U.K. Wye Valley NHS Trust, Hereford, U.K. Business: Renal/Cardiovascular Shannon Lehnbeuter Sensyne Health plc University...
BioCentury | Jan 12, 2019
Finance

Warning: cash needed

...A) 8/21/18 $23.7 NA $52.6 NA Biosolution Co. Ltd. (KOSDAQ:086820) 8/20/18 $38.8 $198.0 $222.1 12% Sensyne Health plc...
BioCentury | Aug 10, 2018
Financial News

Sensyne proposes London IPO

...Data analysis company Sensyne Health plc (Oxford, U.K.) proposed to raise £60 million ($78 million) in an IPO...
...the University of Oxford. In 1993, Bell founded the Wellcome Trust Centre for Human Genetics. Sensyne Health plc...
BioCentury | Aug 7, 2018
Financial News

Sensyne proposes London IPO

...Data analysis company Sensyne Health plc (Oxford, U.K.) proposed to raise £60 million ($78 million) in an IPO...
Items per page:
1 - 8 of 8